AARP worried Congress will roll back Medicare drug changes

Published August 9, 2018 4:28pm ET



The AARP is warning lawmakers not to roll back a change to Medicare that forces drug companies to pay more for seniors’ drug costs.

The senior citizen lobbying group issued a warning Wednesday to lawmakers who are seeking to revisit a decision Congress made in March to force drugmakers to offer a stiffer discount for some Medicare seniors. More than 200 Republican and Democratic representatives have indicated they’re open to undoing the reform.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.